What does CARDON BIO do?

CARDON BIO is a shop in Gent. Public Limited, started on 25 February 2022, 1 establishment.

What is the address of CARDON BIO?

The registered office of CARDON BIO is located at Rijvisschestraat 120, 9052 Gent.

Is CARDON BIO still active?

Yes. According to the CBE (29 October 2026) CARDON BIO is active, legal situation “Normale toestand”, started on 25 February 2022.

Is CARDON BIO registered on Peppol?

Yes, CARDON BIO is registered on the Peppol network with ID 0208:0782633810.

What is the enterprise number of CARDON BIO?

The enterprise number of CARDON BIO is BE0782633810.

When was CARDON BIO founded?

CARDON BIO was founded on 25 February 2022.

Who are the directors of CARDON BIO?

According to the 2025 annual accounts, the directors of CARDON BIO are: Doing Well By Doing Good SA, MaRa BV.

Is CARDON BIO a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 February 2022; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did CARDON BIO make in 2025?

CARDON BIO posted a profit after taxes of € 17,508 in financial year 2025.

What is the revenue of CARDON BIO?

As a small company, CARDON BIO is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 25,626.

CARDON BIO (Public Limited) - Gent - BE0782633810

Dossier CARDON BIO, printed on 29 October 2026 from databakkes.be/en/0782633810/cardon-bio. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Figures corrected NBB

Corrected annual account filed for 2022.

Financials

Financial year 2025

CARDON BIO from Gent, company number BE0782633810, closed financial year 2025 with a result of € 17,508 after tax. For that financial year CARDON BIO recorded a gross margin of € 25,626 and equity of € 88,397. Compared with financial year 2024, the result moved from € 16,823 to € 17,508. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.

What it is worth Growing

€ 88,397

▲ 25% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 17,508

▲ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 122

▼ 69% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 26,397.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 219,673

▲ € 186,248 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 16,490

▲ 13% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -8,792 Gross margin 2022: € -8,792 First fiscal year in the series	€ 2,649 Gross margin 2023: € 2,649 ▲ € 11,441 vs 2022 (€ -8,792) Favourable step	€ 70,397 Gross margin 2024: € 70,397 ▲ € 67,748 vs 2023 (€ 2,649) Favourable step	€ 25,626 Gross margin 2025: € 25,626 ▼ 64% vs 2024 (€ 70,397) Unfavourable step	▼ 64%
Profit after taxes	€ -10,489 Profit after taxes 2022: € -10,489 First fiscal year in the series	€ 2,556 Profit after taxes 2023: € 2,556 ▲ € 13,045 vs 2022 (€ -10,489) Favourable step	€ 16,823 Profit after taxes 2024: € 16,823 ▲ € 14,268 vs 2023 (€ 2,556) Favourable step	€ 17,508 Profit after taxes 2025: € 17,508 ▲ 4% vs 2024 (€ 16,823) Favourable step	▲ 4%
Equity	€ 51,511 Equity 2022: € 51,511 First fiscal year in the series	€ 54,066 Equity 2023: € 54,066 ▲ 5% vs 2022 (€ 51,511) Favourable step	€ 70,890 Equity 2024: € 70,890 ▲ 31% vs 2023 (€ 54,066) Favourable step	€ 88,397 Equity 2025: € 88,397 ▲ 25% vs 2024 (€ 70,890) Favourable step	▲ 25%
Total debts	€ 21,418 Total debts 2022: € 21,418 First fiscal year in the series	€ 22,127 Total debts 2023: € 22,127 ▲ 3% vs 2022 (€ 21,418) Unfavourable step	€ 47,980 Total debts 2024: € 47,980 ▲ 117% vs 2023 (€ 22,127) Unfavourable step	€ 236,163 Total debts 2025: € 236,163 ▲ € 188,184 vs 2024 (€ 47,980) Unfavourable step	▲ € 188,184
Cash	€ 22,643 Cash 2022: € 22,643 First fiscal year in the series	€ 139 Cash 2023: € 139 ▼ 99% vs 2022 (€ 22,643) Unfavourable step	€ 394 Cash 2024: € 394 ▲ 183% vs 2023 (€ 139) Favourable step	€ 122 Cash 2025: € 122 ▼ 69% vs 2024 (€ 394) Unfavourable step	▼ 69%
Retained profit	€ -10,489 Retained profit 2022: € -10,489 First fiscal year in the series	€ -7,934 Retained profit 2023: € -7,934 ▲ € 2,556 vs 2022 (€ -10,489) Favourable step	€ 8,890 Retained profit 2024: € 8,890 ▲ € 16,823 vs 2023 (€ -7,934) Favourable step	€ 26,397 Retained profit 2025: € 26,397 ▲ 197% vs 2024 (€ 8,890) Favourable step	▲ 197%
Balance sheet total	€ 72,928 Balance sheet total 2022: € 72,928 First fiscal year in the series	€ 76,193 Balance sheet total 2023: € 76,193 ▲ 4% vs 2022 (€ 72,928) Unchanged	€ 118,869 Balance sheet total 2024: € 118,869 ▲ 56% vs 2023 (€ 76,193) Unchanged	€ 324,561 Balance sheet total 2025: € 324,561 ▲ 173% vs 2024 (€ 118,869) Unchanged	▲ 173%

Key figures of CARDON BIO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CARDON BIO?

What happened at CARDON BIO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2030 MaRa BV stepped down as director. NBB
2028 Doing Well By Doing Good SA stepped down as director. NBB
Aug 28, 2026 New annual accounts for financial year 2025: profit of € 17,508 (▲ 4% vs 2024). filed late Source: NBB ↗
2025 MaRa BV became a director. NBB
Feb 25, 2022 New establishment in Gent. KBO
2022 Doing Well By Doing Good SA became a director. NBB
Feb 25, 2022 Start of the company according to the CBE. KBO

In short

From € 10,489 loss in 2022 to € 17,508 profit in 2025.

Paid € 9,352 in corporate taxes since 2022.

Best year ever: 2025, with € 17,508 profit.

Original PDFs at the National Bank ↗

Management

Akihz 16.1%

The stake of Akihz comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

CARDON BIO

The shares are held by Akihz (16.1%).

Directors

According to the 2025 annual accounts

Doing Well By Doing Good SA

Director · represented by Christiaan Cardon

Also active at: DOING WELL BY DOING GOOD, Puxano, CELL-CELL BIO, BELLEVUE

since 2022 · until 2028

MaRa BV

Director · represented by Hendrik Thys

Also active at: Puxano, CELL-CELL BIO

since 2025 · until 2030

Shareholders

Akihz

16.1%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rijvisschestraat 120

9052 Gent

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.

All companies at this address →

RNA Pioneering

€ -111,461 gross margin · 2025

DOING WELL BY DOING GOOD same network

€ 27,550 gross margin · 2025

Ziphius

€ 2.4 million gross margin · 2025

CELL-CELL BIO same network

€ 777,487 gross margin · 2025

BORDEAUX I

€ -3,685 gross margin · 2025

+1 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0782.633.810

VAT number

BE 0782.633.810

Registered office

Rijvisschestraat 120, 9052 Gent

Names & denominations

CARDON BIO

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

25 February 2022

Peppol

Active · Active since 24 Nov 2023

Contact

saigapharma.be [email protected]

Activities · NACE

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

CARDON BIO

Warning lights

Financials

What happened to CARDON BIO?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions